These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 19830729)

  • 1. A role for endobrevin/VAMP8 in CTL lytic granule exocytosis.
    Loo LS; Hwang LA; Ong YM; Tay HS; Wang CC; Hong W
    Eur J Immunol; 2009 Dec; 39(12):3520-8. PubMed ID: 19830729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The exocytosis of lytic granules is impaired in Vti1b- or Vamp8-deficient CTL leading to a reduced cytotoxic activity following antigen-specific activation.
    Dressel R; Elsner L; Novota P; Kanwar N; Fischer von Mollard G
    J Immunol; 2010 Jul; 185(2):1005-14. PubMed ID: 20543108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of cytotoxic T lymphocyte function in Chediak-Higashi syndrome arises from a secretory defect that prevents lytic granule exocytosis.
    Baetz K; Isaaz S; Griffiths GM
    J Immunol; 1995 Jun; 154(11):6122-31. PubMed ID: 7751653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly lytic in vivo primed cytolytic T lymphocytes devoid of lytic granules and BLT-esterase activity acquire these constituents in the presence of T cell growth factors upon blast transformation in vitro.
    Berke G; Rosen D
    J Immunol; 1988 Sep; 141(5):1429-36. PubMed ID: 3261748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway.
    Isaaz S; Baetz K; Olsen K; Podack E; Griffiths GM
    Eur J Immunol; 1995 Apr; 25(4):1071-9. PubMed ID: 7737276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An anergic cytotoxic T lymphocyte clone exhibits granule exocytosis-mediated cytotoxicity.
    Kuwano K; Akashi A; Arai S
    Cell Immunol; 1998 May; 185(2):114-22. PubMed ID: 9636689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exocytosis of cytolytic granules may not be required for target cell lysis by cytotoxic T-lymphocytes.
    Trenn G; Takayama H; Sitkovsky MV
    Nature; 1987 Nov 5-11; 330(6143):72-4. PubMed ID: 3118213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centrosome polarization delivers secretory granules to the immunological synapse.
    Stinchcombe JC; Majorovits E; Bossi G; Fuller S; Griffiths GM
    Nature; 2006 Sep; 443(7110):462-5. PubMed ID: 17006514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of primary T lymphocytes results in lysosome development and polarized granule exocytosis in CD4+ and CD8+ subsets, whereas expression of lytic molecules confers cytotoxicity to CD8+ T cells.
    Shen DT; Ma JS; Mather J; Vukmanovic S; Radoja S
    J Leukoc Biol; 2006 Oct; 80(4):827-37. PubMed ID: 16891618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganglioside inhibition of CD8+ T cell cytotoxicity: interference with lytic granule trafficking and exocytosis.
    Lee HC; Wondimu A; Liu Y; Ma JS; Radoja S; Ladisch S
    J Immunol; 2012 Oct; 189(7):3521-7. PubMed ID: 22956583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VAMP8-dependent fusion of recycling endosomes with the plasma membrane facilitates T lymphocyte cytotoxicity.
    Marshall MR; Pattu V; Halimani M; Maier-Peuschel M; Müller ML; Becherer U; Hong W; Hoth M; Tschernig T; Bryceson YT; Rettig J
    J Cell Biol; 2015 Jul; 210(1):135-51. PubMed ID: 26124288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavior and Properties of Mature Lytic Granules at the Immunological Synapse of Human Cytotoxic T Lymphocytes.
    Ming M; Schirra C; Becherer U; Stevens DR; Rettig J
    PLoS One; 2015; 10(8):e0135994. PubMed ID: 26296096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C delta localizes to secretory lysosomes in CD8+ CTL and directly mediates TCR signals leading to granule exocytosis-mediated cytotoxicity.
    Ma JS; Haydar TF; Radoja S
    J Immunol; 2008 Oct; 181(7):4716-22. PubMed ID: 18802074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntaxin7 is required for lytic granule release from cytotoxic T lymphocytes.
    Pattu V; Qu B; Marshall M; Becherer U; Junker C; Matti U; Schwarz EC; Krause E; Hoth M; Rettig J
    Traffic; 2011 Jul; 12(7):890-901. PubMed ID: 21438968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of lymphocyte-mediated cytolysis: functional cytolytic T cells lacking perforin and granzymes.
    Berke G; Rosen D; Ronen D
    Immunology; 1993 Jan; 78(1):105-12. PubMed ID: 8436395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfection of mouse cytotoxic T lymphocyte with an antisense granzyme A vector reduces lytic activity.
    Talento A; Nguyen M; Law S; Wu JK; Poe M; Blake JT; Patel M; Wu TJ; Manyak CL; Silberklang M
    J Immunol; 1992 Dec; 149(12):4009-15. PubMed ID: 1460287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium influx and signaling in cytotoxic T-lymphocyte lytic granule exocytosis.
    Pores-Fernando AT; Zweifach A
    Immunol Rev; 2009 Sep; 231(1):160-73. PubMed ID: 19754896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.
    Lancki DW; Kaper BP; Fitch FW
    J Immunol; 1989 Jan; 142(2):416-24. PubMed ID: 2492047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acidification is essential for maintaining the structure and function of lytic granules of CTL. Effect of concanamycin A, an inhibitor of vacuolar type H(+)-ATPase, on CTL-mediated cytotoxicity.
    Kataoka T; Takaku K; Magae J; Shinohara N; Takayama H; Kondo S; Nagai K
    J Immunol; 1994 Nov; 153(9):3938-47. PubMed ID: 7930604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
    Riquelme E; Carreño LJ; González PA; Kalergis AM
    Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.